Mostrar el registro sencillo del ítem

dc.contributor.author
Villaverde, Marcela Solange  
dc.contributor.author
Gil Cardeza, Maria Lourdes  
dc.contributor.author
Glikin, Gerardo Claudio  
dc.contributor.author
Finocchiaro, Liliana Maria Elena  
dc.date.available
2022-07-18T13:28:44Z  
dc.date.issued
2012-06  
dc.identifier.citation
Villaverde, Marcela Solange; Gil Cardeza, Maria Lourdes; Glikin, Gerardo Claudio; Finocchiaro, Liliana Maria Elena; Interferon-Β lipofection II: Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-Β gene transfer to human tumor cells; Nature Publishing Group; Cancer Gene Therapy; 19; 6; 6-2012; 420-430  
dc.identifier.issn
0929-1903  
dc.identifier.uri
http://hdl.handle.net/11336/162317  
dc.description.abstract
We evaluated the cytotoxic effects (apoptosis, necrosis and early senescence) of human interferon-B (hIFNB) gene lipofection. The cytotoxicity of hIFNB gene lipofection resulted equivalent to that of the corresponding addition of the recombinant protein (rhIFNB) on human tumor cell lines derived from Ewing´s sarcoma (EW7 and COH) and colon (HT-29) carcinomas. However, it was stronger than rhIFNB on melanoma (M8) and breast adenocarcinoma (MCF7). To reveal the mechanisms involved in these differences, we compared the effects of hIFNB gene and rhIFNB protein on EW7 and M8 (sensitive and resistant to rhIFNB protein, respectively). Lipofection with hIFNB gene caused a mitochondrial potential decrease simultaneous with an increase of oxidative stress in both cell lines. However, rhIFNB protein displayed the same pattern of response only in EW7-sensitive cell line. The great bystander effect of the hIFNB gene lipofection, involving the production of reactive oxygen species, would be among the main causes of its success. In EW7, this effect killed >60% of EW7 cell population, even though only 1% of cells were expressing the transgene. As hIFNB gene was effective even in the rhIFNB protein-resistant M8 cell line and in a way not limited by low lipofection efficiency, these results strongly support the clinical potential of this approach.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Nature Publishing Group  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
APOPTOSIS  
dc.subject
EWING'S SARCOMA  
dc.subject
INTERFERON-B  
dc.subject
LIPOFECTION  
dc.subject
MELANOMA  
dc.subject
REACTIVE OXYGEN SPECIES  
dc.subject.classification
Tecnologías que involucran la manipulación de células, tejidos, órganos o todo el organismo  
dc.subject.classification
Biotecnología de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Interferon-Β lipofection II: Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-Β gene transfer to human tumor cells  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2022-06-21T18:33:02Z  
dc.journal.volume
19  
dc.journal.number
6  
dc.journal.pagination
420-430  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Villaverde, Marcela Solange. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina  
dc.description.fil
Fil: Gil Cardeza, Maria Lourdes. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina  
dc.description.fil
Fil: Glikin, Gerardo Claudio. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina  
dc.description.fil
Fil: Finocchiaro, Liliana Maria Elena. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina  
dc.journal.title
Cancer Gene Therapy  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/cgt201219  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1038/cgt.2012.19